This document provides an overview of optic disc swelling, including the anatomy of the optic nerve, blood supply, causes of optic disc swelling like papilledema and pseudopapilledema, differential diagnosis, and treatments. Key points include the definition of papilledema as optic disc swelling due to increased intracranial pressure, distinguishing features between papilledema and pseudopapilledema, grading scales for papilledema severity, causes of increased ICP like idiopathic intracranial hypertension, and distinguishing anterior ischemic optic neuropathy from optic neuritis.
1. Differential diagnosis of disc edema includes conditions like papilledema, optic neuritis, ischemic optic neuropathy, diabetic papillopathy, and hypertensive retinopathy.
2. Papilledema is caused by increased intracranial pressure and presents with bilateral disc swelling and normal vision, while optic neuritis typically causes unilateral vision loss and eye pain.
3. Diabetic papillopathy presents as transient unilateral or bilateral disc edema that resolves within months without vision loss, while malignant hypertension can lead to bilateral disc edema and vision changes as part of hypertensive retinopathy.
Normal tension glaucoma, also known as low tension glaucoma, is characterized by open angle glaucoma with typical optic nerve damage but intraocular pressure that is consistently normal or only slightly elevated. It has several risk factors such as older age, female sex, East Asian ethnicity, family history of glaucoma, and thin central corneal thickness. The pathogenesis involves vascular dysfunction, autoimmune mechanisms, vascular inflammation, and genetic mutations. Diagnosis involves a detailed medical history, eye examination, visual field testing, and sometimes additional imaging or blood work. Treatment aims to lower intraocular pressure by 30% using topical eye drops, laser trabeculoplasty, or filtering surgeries along with controlling any underlying vascular problems
The presentation was made under the wise guidance of my professor DR.(prof) P. Rawat (MGMMC & M.Y. HOSPITAL, INDORE).It covers the essential aspects of optic neuritis & optic atrophy.
Based on the visual field series shown, it appears the patient is experiencing lens artifact on the visual fields over time. The sharp nasal step seen on earlier fields is likely not real. My management would be:
- Discontinue glaucoma treatment since visual fields are unreliable due to lens artifact
- Perform gonioscopy and review optic nerve/retinal nerve fiber layer to evaluate for glaucoma
- Consider cataract surgery to remove lens artifact on future visual fields
- Counsel patient that visual fields were unreliable due to cataract and glaucoma status cannot be determined from VF alone
The key things are to not rely solely on unreliable visual fields for glaucoma diagnosis or management, and address the underlying cause
This document discusses various types of ischemic optic neuropathy (ION). It begins by introducing ION as a major cause of vision loss and outlines its classification into anterior and posterior forms. It then details the anatomy and vascular supply of the optic nerve, risk factors for ION such as nocturnal blood pressure changes, and the pathogenesis involving hypoperfusion and axonal swelling. Non-arteritic anterior ION is described as the most common type, while posterior ION and arteritic forms are less prevalent but can involve vascular inflammation. The document outlines signs, investigations, management approaches including steroids, and variable prognoses for the different ION types.
This document discusses various causes of optic disc edema. It begins by defining disc edema as swelling of the optic disc that can be caused by active or passive factors other than papilledema. Several pseudoedemas are described including drusen, myelinated fibers, tilted discs, and hypoplastic discs. True disc edemas can result from inflammation, vascular issues like CRVO, infiltrative diseases, or papilledema from increased intracranial pressure. Papilledema is usually bilateral non-inflammatory swelling caused by conditions that raise ICP like brain tumors, infections, pseudotumor cerebri, or venous sinus thrombosis. The pathogenesis and features of optic neuritis, multiple sclerosis, and papille
This document discusses the effects of diabetes on the eye. It begins with an introduction to diabetes mellitus and its long-term damaging effects on organs. It then covers the two main types of diabetes and their characteristics. The document discusses the pathogenesis of diabetic retinopathy and how high blood glucose damages blood vessels in the eye. It provides a detailed overview of the stages of diabetic retinopathy from mild non-proliferative to proliferative and potential vision loss outcomes. Management strategies like glucose control, laser therapy, anti-VEGF drugs, and vitrectomy are summarized.
This document discusses papilloedema, which refers to optic disc swelling caused by increased intracranial pressure. It defines various types of optic disc swelling including unilateral, bilateral, and papilloedema. It also discusses pseudo-papilloedema. The causes, signs, symptoms, diagnostic workup, and grading scale of papilloedema are explained in detail. Treatment options for increased intracranial pressure including idiopathic intracranial hypertension involve medical management with carbonic anhydrase inhibitors and weight loss as well as potential surgical interventions.
1. Differential diagnosis of disc edema includes conditions like papilledema, optic neuritis, ischemic optic neuropathy, diabetic papillopathy, and hypertensive retinopathy.
2. Papilledema is caused by increased intracranial pressure and presents with bilateral disc swelling and normal vision, while optic neuritis typically causes unilateral vision loss and eye pain.
3. Diabetic papillopathy presents as transient unilateral or bilateral disc edema that resolves within months without vision loss, while malignant hypertension can lead to bilateral disc edema and vision changes as part of hypertensive retinopathy.
Normal tension glaucoma, also known as low tension glaucoma, is characterized by open angle glaucoma with typical optic nerve damage but intraocular pressure that is consistently normal or only slightly elevated. It has several risk factors such as older age, female sex, East Asian ethnicity, family history of glaucoma, and thin central corneal thickness. The pathogenesis involves vascular dysfunction, autoimmune mechanisms, vascular inflammation, and genetic mutations. Diagnosis involves a detailed medical history, eye examination, visual field testing, and sometimes additional imaging or blood work. Treatment aims to lower intraocular pressure by 30% using topical eye drops, laser trabeculoplasty, or filtering surgeries along with controlling any underlying vascular problems
The presentation was made under the wise guidance of my professor DR.(prof) P. Rawat (MGMMC & M.Y. HOSPITAL, INDORE).It covers the essential aspects of optic neuritis & optic atrophy.
Based on the visual field series shown, it appears the patient is experiencing lens artifact on the visual fields over time. The sharp nasal step seen on earlier fields is likely not real. My management would be:
- Discontinue glaucoma treatment since visual fields are unreliable due to lens artifact
- Perform gonioscopy and review optic nerve/retinal nerve fiber layer to evaluate for glaucoma
- Consider cataract surgery to remove lens artifact on future visual fields
- Counsel patient that visual fields were unreliable due to cataract and glaucoma status cannot be determined from VF alone
The key things are to not rely solely on unreliable visual fields for glaucoma diagnosis or management, and address the underlying cause
This document discusses various types of ischemic optic neuropathy (ION). It begins by introducing ION as a major cause of vision loss and outlines its classification into anterior and posterior forms. It then details the anatomy and vascular supply of the optic nerve, risk factors for ION such as nocturnal blood pressure changes, and the pathogenesis involving hypoperfusion and axonal swelling. Non-arteritic anterior ION is described as the most common type, while posterior ION and arteritic forms are less prevalent but can involve vascular inflammation. The document outlines signs, investigations, management approaches including steroids, and variable prognoses for the different ION types.
This document discusses various causes of optic disc edema. It begins by defining disc edema as swelling of the optic disc that can be caused by active or passive factors other than papilledema. Several pseudoedemas are described including drusen, myelinated fibers, tilted discs, and hypoplastic discs. True disc edemas can result from inflammation, vascular issues like CRVO, infiltrative diseases, or papilledema from increased intracranial pressure. Papilledema is usually bilateral non-inflammatory swelling caused by conditions that raise ICP like brain tumors, infections, pseudotumor cerebri, or venous sinus thrombosis. The pathogenesis and features of optic neuritis, multiple sclerosis, and papille
This document discusses the effects of diabetes on the eye. It begins with an introduction to diabetes mellitus and its long-term damaging effects on organs. It then covers the two main types of diabetes and their characteristics. The document discusses the pathogenesis of diabetic retinopathy and how high blood glucose damages blood vessels in the eye. It provides a detailed overview of the stages of diabetic retinopathy from mild non-proliferative to proliferative and potential vision loss outcomes. Management strategies like glucose control, laser therapy, anti-VEGF drugs, and vitrectomy are summarized.
This document discusses papilloedema, which refers to optic disc swelling caused by increased intracranial pressure. It defines various types of optic disc swelling including unilateral, bilateral, and papilloedema. It also discusses pseudo-papilloedema. The causes, signs, symptoms, diagnostic workup, and grading scale of papilloedema are explained in detail. Treatment options for increased intracranial pressure including idiopathic intracranial hypertension involve medical management with carbonic anhydrase inhibitors and weight loss as well as potential surgical interventions.
UBM and ASOCT provide high-resolution cross-sectional images of the anterior segment including the cornea, anterior chamber, angle, and iris. ASOCT uses optical coherence tomography with a wavelength of 1310nm for improved penetration and reduced retinal damage compared to posterior segment OCT. It allows high-speed imaging of dynamic structures. ASOCT has applications in assessing corneal diseases and procedures, glaucoma (including angle anatomy and iridotomy evaluation), and intraocular lens implantation. Measurements of angle width parameters help evaluate angle closure risk. While valuable for objective angle assessment, ASOCT cannot image all anatomical structures involved in glaucoma.
This document provides an overview of macular holes, including:
- Classification into primary (idiopathic) and secondary holes. Primary holes are caused by vitreous traction while secondary have other causes like trauma.
- Stages of macular hole formation based on Gass classification from early detachment to full thickness hole.
- Surgical treatment involves vitrectomy to relieve traction along with internal limiting membrane peeling which has good outcomes in improving vision.
- Differential diagnosis includes epiretinal membranes and pseudoholes which have different presentations and prognoses.
Pigmentary glaucoma - Dr Shylesh B DabkeShylesh Dabke
Pigment Dispersion Syndrome (PDS) involves abnormal amounts of pigment released from the iris that deposit throughout the eye. It can sometimes progress to Pigmentary Glaucoma (PG). PDS is more common in young, white, myopic males and has genetic links. Theories for its pathogenesis include mechanical abrasion between the iris and lens zonules or abnormal iris cell degeneration. Over time, PDS can cause increased eye pressure and vision loss from PG if not properly treated with medications, laser procedures, or surgery.
Optic neuritis is an inflammation of the optic nerve that can be divided into 3 types based on appearance: papillitis, neuroretinitis, and retrobulbar neuritis. Papillitis is most common in children and involves edema and hyperemia of the optic disc. Neuroretinitis also involves the retinal nerve fiber layer and macula. Retrobulbar neuritis most commonly affects adults and the optic disc may appear normal initially. Causes include demyelinating disorders like multiple sclerosis, infections, immune disorders, and metabolic conditions. Treatment involves steroids like intravenous methylprednisolone to hasten recovery of vision, with the goal of improving outcomes and delaying development of multiple sclerosis
This document summarizes a presentation on normal tension glaucoma (NTG). It begins with an introduction defining NTG as open-angle glaucoma with characteristic optic nerve damage and visual field defects in patients with consistently low intraocular pressure (IOP) below 21 mmHg. It then describes a case presentation of a 47-year-old female patient. The remainder of the document discusses the history, examination, investigations, differential diagnosis, management, pathogenesis involving both IOP-dependent and independent factors, and epidemiology of NTG. Key points are that lowering IOP through medication or surgery can help prevent progression even in NTG, and that NTG may have an underlying vascular component involving low ocular perfusion pressure
This document discusses target intraocular pressure (IOP) for treating glaucoma. It defines target IOP as the upper limit of IOP that prevents further glaucoma damage. Establishing an individualized target IOP is important to slow retinal ganglion cell loss and glaucoma progression over a patient's lifetime with minimal effects on quality of life. The target IOP should be based on factors like the amount of existing eye damage, maximum past IOP levels, life expectancy, and risk factors. The target is dynamic and must be reevaluated periodically, lowering it if damage progresses or raising it if side effects occur from low IOP. Clinical studies show that greater IOP reductions correlate with less glaucoma progression
The document provides an overview of clinical evaluation of optic disc changes. It discusses examining the papillary changes including size, shape, neuroretinal rim, cupping and color. It also discusses vascular changes like nasalization of vessels and bayoneting of vessels. Peripapillary changes like RNFL defects, hemorrhages and gray crescent are also covered. The document outlines different staging systems to classify optic disc changes including the Disc Damage Likelihood Scale which quantifies glaucomatous damage based on rim width and disc size.
1) A 75-year-old male presented with gradual decreased vision in both eyes over the past 3 years. He has a history of cataracts surgery in both eyes.
2) Examination found posterior capsular opacification in both eyes, worse in the left eye. The left eye also showed an irregular pupil, RAPD, and a dull fundus reflex.
3) The patient underwent YAG capsulotomy in the left eye. At 1-week follow-up, his vision had improved but was still reduced in the left eye, likely due to underlying retinal pathology. He was advised to continue his current prescription and follow-up as needed.
This document discusses branch retinal vein occlusion (BRVO), including its pathogenesis, clinical features, complications, investigations, and management. BRVO is caused by obstruction of one of the retinal veins, usually at the arteriovenous crossing point. It can lead to macular edema, neovascularization, vitreous hemorrhage, and retinal detachment. Treatment involves anti-VEGF injections, steroids, laser photocoagulation, and occasionally surgery. Several clinical trials have evaluated therapies for BRVO, finding that anti-VEGF drugs and steroids reduce macular edema but laser provides little additional benefit when combined with anti-VEGF treatment.
Retinal vasculitis refers to the inflammation of the retinal vessel resulting in evident clinical manifestations i.e. vascular sheathing, leakage and occlusion. This presentation covers the etiology, pathogenesis, clinical features, diagnosis and management of this spectrum of retinal disease.
This document discusses the diagnosis of pre-perimetric glaucoma. It begins by defining pre-perimetric glaucoma as optic nerve abnormalities seen on structural tests with normal visual fields. It then discusses the need for early diagnosis before functional changes occur. Various functional tests are described like standard automated perimetry, short wavelength automated perimetry, frequency doubling technology, and others. Structural tests like confocal scanning laser ophthalmoscopy, optical coherence tomography, and their principles are summarized.
This document provides information on optic neuritis, including its definition, etiology, pathology, clinical features, diagnosis, and treatment. Some key points:
- Optic neuritis is an inflammatory condition of the optic nerve that can cause visual loss. Common causes include multiple sclerosis, infections, and autoimmune disorders.
- Clinical features include sudden visual loss or blurring in one eye, pain with eye movement, and abnormal pupil response to light. Diagnosis is made based on symptoms and MRI findings.
- Treatment involves corticosteroids via IV or oral administration. The Optic Neuritis Treatment Trial found IV methylprednisolone can help delay conversion to multiple sclerosis.
This document discusses the evaluation and management of uveitic glaucoma. It begins by defining uveitic glaucoma and noting that 10% of uveitis patients will develop elevated intraocular pressure (IOP) or open-angle glaucoma. The pathophysiology of secondary glaucoma from uveitis is described. Treatment principles aim to reduce inflammation, control IOP, and prevent permanent damage. Cycloplegics, corticosteroids, and sometimes immunosuppressants are used to control inflammation. Topical medications, laser treatments, and surgeries may be needed to control IOP depending on the mechanism and severity. Close monitoring is important with this patient population.
The document summarizes different techniques used to examine the fundus of the eye, including:
1. Direct ophthalmoscopy provides an upright 15x view of the posterior pole but no stereopsis. Indirect ophthalmoscopy uses lenses from 14-30D for an inverted 40-50 degree view with stereopsis.
2. Slit lamp biomicroscopy provides a 30-40 degree inverted view at higher magnifications up to 16x using a +78D lens.
3. A -55D lens provides a virtual upright view for examining the optic nerve and retina through dilated pupils. A contact lens combines high magnification and stereopsis for detailed macular exams.
4. Wide
This document discusses different methods for examining the fundus of the eye, including direct ophthalmoscopy, indirect ophthalmoscopy, and indirect slit lamp biomicroscopy. It provides details on how each method works, including magnification, field of view, advantages, and disadvantages. Key structures that can be observed during fundus examination are also described, such as the optic disc, blood vessels, macula, and signs of common eye conditions like glaucoma, optic nerve diseases, retinal problems, and diabetes-related changes.
This document discusses papilledema, which is swelling of the optic disc due to increased intracranial pressure. It defines papilledema and outlines its causes, signs, symptoms, grading, histopathology, investigations, differential diagnosis, and treatment. The main points are that papilledema is caused by increased intracranial pressure, it can be graded on a scale from 0-5 based on severity, and treatment involves addressing the underlying cause of pressure increase as well as surgical decompression in severe cases to prevent vision loss.
The document discusses visual field testing in glaucoma. It defines the visual field and perimetry, and describes the major types of clinical perimetry tests including full threshold, SITA standard, and SITA fast on Humphrey and normal, dynamic, and TOP strategies on Octopus. It explains parameters such as test patterns, reliability, age-corrected plots, tests like GHT and Bebie curve, and global indices including MD, PSD, SF, and CPSD. The purpose of visual field testing in glaucoma is to detect and monitor disease by measuring light sensitivity across the retinal field.
- Visual field examination tests the peripheral sensitivity of the retina and visual pathways. It is important for assessing topographic sensitivity and detecting visual field defects.
- Automated perimetry provides standardized, quantitative tests to measure threshold sensitivity across the visual field. It allows for reliable long-term monitoring to detect glaucomatous progression.
- Interpretation of visual field tests involves analyzing parameters like total deviation plots, pattern deviation plots, and global indices to identify patterns indicative of glaucoma according to established criteria. Clinical correlation with optic nerve examination is also important.
This document discusses cytomegalovirus retinitis (CMVR), which is caused by cytomegalovirus infection and most commonly affects immunocompromised individuals. It presents the pathogenesis, clinical presentation, diagnosis, differential diagnosis and treatment of CMVR. The clinical presentation of CMVR ranges from asymptomatic to vision loss and includes retinal lesions that progress in a brushfire manner. Diagnosis involves clinical examination supplemented by laboratory tests when needed. Treatment involves antiviral drugs like ganciclovir, foscarnet and cidofovir.
The document discusses various potential causes of optic disc swelling including:
1. Papilledema due to increased intracranial pressure from space occupying lesions, decreased CSF drainage, or idiopathic intracranial hypertension.
2. Optic neuritis which is inflammation of the optic nerve.
3. Anterior ischemic optic neuropathy (AION) which is infarction of the optic nerve head.
It provides details on presentations, ocular findings, and treatments for some of these conditions.
This document defines and describes papilledema, providing information on its pathophysiology, causes, symptoms, signs, grading, investigations, and treatment. Papilledema is passive swelling of the optic nerve head due to increased intracranial pressure. It is usually bilateral but can occasionally be unilateral. Increased ICP leads to increased optic nerve tissue pressure, altering the pressure gradient and causing swelling. Common causes include space occupying lesions, idiopathic intracranial hypertension, and cerebral edema. Signs include elevation and blurring of the optic disc margin. Treatment is directed at the underlying cause, with resolution of papilledema typically occurring within weeks of treatment.
UBM and ASOCT provide high-resolution cross-sectional images of the anterior segment including the cornea, anterior chamber, angle, and iris. ASOCT uses optical coherence tomography with a wavelength of 1310nm for improved penetration and reduced retinal damage compared to posterior segment OCT. It allows high-speed imaging of dynamic structures. ASOCT has applications in assessing corneal diseases and procedures, glaucoma (including angle anatomy and iridotomy evaluation), and intraocular lens implantation. Measurements of angle width parameters help evaluate angle closure risk. While valuable for objective angle assessment, ASOCT cannot image all anatomical structures involved in glaucoma.
This document provides an overview of macular holes, including:
- Classification into primary (idiopathic) and secondary holes. Primary holes are caused by vitreous traction while secondary have other causes like trauma.
- Stages of macular hole formation based on Gass classification from early detachment to full thickness hole.
- Surgical treatment involves vitrectomy to relieve traction along with internal limiting membrane peeling which has good outcomes in improving vision.
- Differential diagnosis includes epiretinal membranes and pseudoholes which have different presentations and prognoses.
Pigmentary glaucoma - Dr Shylesh B DabkeShylesh Dabke
Pigment Dispersion Syndrome (PDS) involves abnormal amounts of pigment released from the iris that deposit throughout the eye. It can sometimes progress to Pigmentary Glaucoma (PG). PDS is more common in young, white, myopic males and has genetic links. Theories for its pathogenesis include mechanical abrasion between the iris and lens zonules or abnormal iris cell degeneration. Over time, PDS can cause increased eye pressure and vision loss from PG if not properly treated with medications, laser procedures, or surgery.
Optic neuritis is an inflammation of the optic nerve that can be divided into 3 types based on appearance: papillitis, neuroretinitis, and retrobulbar neuritis. Papillitis is most common in children and involves edema and hyperemia of the optic disc. Neuroretinitis also involves the retinal nerve fiber layer and macula. Retrobulbar neuritis most commonly affects adults and the optic disc may appear normal initially. Causes include demyelinating disorders like multiple sclerosis, infections, immune disorders, and metabolic conditions. Treatment involves steroids like intravenous methylprednisolone to hasten recovery of vision, with the goal of improving outcomes and delaying development of multiple sclerosis
This document summarizes a presentation on normal tension glaucoma (NTG). It begins with an introduction defining NTG as open-angle glaucoma with characteristic optic nerve damage and visual field defects in patients with consistently low intraocular pressure (IOP) below 21 mmHg. It then describes a case presentation of a 47-year-old female patient. The remainder of the document discusses the history, examination, investigations, differential diagnosis, management, pathogenesis involving both IOP-dependent and independent factors, and epidemiology of NTG. Key points are that lowering IOP through medication or surgery can help prevent progression even in NTG, and that NTG may have an underlying vascular component involving low ocular perfusion pressure
This document discusses target intraocular pressure (IOP) for treating glaucoma. It defines target IOP as the upper limit of IOP that prevents further glaucoma damage. Establishing an individualized target IOP is important to slow retinal ganglion cell loss and glaucoma progression over a patient's lifetime with minimal effects on quality of life. The target IOP should be based on factors like the amount of existing eye damage, maximum past IOP levels, life expectancy, and risk factors. The target is dynamic and must be reevaluated periodically, lowering it if damage progresses or raising it if side effects occur from low IOP. Clinical studies show that greater IOP reductions correlate with less glaucoma progression
The document provides an overview of clinical evaluation of optic disc changes. It discusses examining the papillary changes including size, shape, neuroretinal rim, cupping and color. It also discusses vascular changes like nasalization of vessels and bayoneting of vessels. Peripapillary changes like RNFL defects, hemorrhages and gray crescent are also covered. The document outlines different staging systems to classify optic disc changes including the Disc Damage Likelihood Scale which quantifies glaucomatous damage based on rim width and disc size.
1) A 75-year-old male presented with gradual decreased vision in both eyes over the past 3 years. He has a history of cataracts surgery in both eyes.
2) Examination found posterior capsular opacification in both eyes, worse in the left eye. The left eye also showed an irregular pupil, RAPD, and a dull fundus reflex.
3) The patient underwent YAG capsulotomy in the left eye. At 1-week follow-up, his vision had improved but was still reduced in the left eye, likely due to underlying retinal pathology. He was advised to continue his current prescription and follow-up as needed.
This document discusses branch retinal vein occlusion (BRVO), including its pathogenesis, clinical features, complications, investigations, and management. BRVO is caused by obstruction of one of the retinal veins, usually at the arteriovenous crossing point. It can lead to macular edema, neovascularization, vitreous hemorrhage, and retinal detachment. Treatment involves anti-VEGF injections, steroids, laser photocoagulation, and occasionally surgery. Several clinical trials have evaluated therapies for BRVO, finding that anti-VEGF drugs and steroids reduce macular edema but laser provides little additional benefit when combined with anti-VEGF treatment.
Retinal vasculitis refers to the inflammation of the retinal vessel resulting in evident clinical manifestations i.e. vascular sheathing, leakage and occlusion. This presentation covers the etiology, pathogenesis, clinical features, diagnosis and management of this spectrum of retinal disease.
This document discusses the diagnosis of pre-perimetric glaucoma. It begins by defining pre-perimetric glaucoma as optic nerve abnormalities seen on structural tests with normal visual fields. It then discusses the need for early diagnosis before functional changes occur. Various functional tests are described like standard automated perimetry, short wavelength automated perimetry, frequency doubling technology, and others. Structural tests like confocal scanning laser ophthalmoscopy, optical coherence tomography, and their principles are summarized.
This document provides information on optic neuritis, including its definition, etiology, pathology, clinical features, diagnosis, and treatment. Some key points:
- Optic neuritis is an inflammatory condition of the optic nerve that can cause visual loss. Common causes include multiple sclerosis, infections, and autoimmune disorders.
- Clinical features include sudden visual loss or blurring in one eye, pain with eye movement, and abnormal pupil response to light. Diagnosis is made based on symptoms and MRI findings.
- Treatment involves corticosteroids via IV or oral administration. The Optic Neuritis Treatment Trial found IV methylprednisolone can help delay conversion to multiple sclerosis.
This document discusses the evaluation and management of uveitic glaucoma. It begins by defining uveitic glaucoma and noting that 10% of uveitis patients will develop elevated intraocular pressure (IOP) or open-angle glaucoma. The pathophysiology of secondary glaucoma from uveitis is described. Treatment principles aim to reduce inflammation, control IOP, and prevent permanent damage. Cycloplegics, corticosteroids, and sometimes immunosuppressants are used to control inflammation. Topical medications, laser treatments, and surgeries may be needed to control IOP depending on the mechanism and severity. Close monitoring is important with this patient population.
The document summarizes different techniques used to examine the fundus of the eye, including:
1. Direct ophthalmoscopy provides an upright 15x view of the posterior pole but no stereopsis. Indirect ophthalmoscopy uses lenses from 14-30D for an inverted 40-50 degree view with stereopsis.
2. Slit lamp biomicroscopy provides a 30-40 degree inverted view at higher magnifications up to 16x using a +78D lens.
3. A -55D lens provides a virtual upright view for examining the optic nerve and retina through dilated pupils. A contact lens combines high magnification and stereopsis for detailed macular exams.
4. Wide
This document discusses different methods for examining the fundus of the eye, including direct ophthalmoscopy, indirect ophthalmoscopy, and indirect slit lamp biomicroscopy. It provides details on how each method works, including magnification, field of view, advantages, and disadvantages. Key structures that can be observed during fundus examination are also described, such as the optic disc, blood vessels, macula, and signs of common eye conditions like glaucoma, optic nerve diseases, retinal problems, and diabetes-related changes.
This document discusses papilledema, which is swelling of the optic disc due to increased intracranial pressure. It defines papilledema and outlines its causes, signs, symptoms, grading, histopathology, investigations, differential diagnosis, and treatment. The main points are that papilledema is caused by increased intracranial pressure, it can be graded on a scale from 0-5 based on severity, and treatment involves addressing the underlying cause of pressure increase as well as surgical decompression in severe cases to prevent vision loss.
The document discusses visual field testing in glaucoma. It defines the visual field and perimetry, and describes the major types of clinical perimetry tests including full threshold, SITA standard, and SITA fast on Humphrey and normal, dynamic, and TOP strategies on Octopus. It explains parameters such as test patterns, reliability, age-corrected plots, tests like GHT and Bebie curve, and global indices including MD, PSD, SF, and CPSD. The purpose of visual field testing in glaucoma is to detect and monitor disease by measuring light sensitivity across the retinal field.
- Visual field examination tests the peripheral sensitivity of the retina and visual pathways. It is important for assessing topographic sensitivity and detecting visual field defects.
- Automated perimetry provides standardized, quantitative tests to measure threshold sensitivity across the visual field. It allows for reliable long-term monitoring to detect glaucomatous progression.
- Interpretation of visual field tests involves analyzing parameters like total deviation plots, pattern deviation plots, and global indices to identify patterns indicative of glaucoma according to established criteria. Clinical correlation with optic nerve examination is also important.
This document discusses cytomegalovirus retinitis (CMVR), which is caused by cytomegalovirus infection and most commonly affects immunocompromised individuals. It presents the pathogenesis, clinical presentation, diagnosis, differential diagnosis and treatment of CMVR. The clinical presentation of CMVR ranges from asymptomatic to vision loss and includes retinal lesions that progress in a brushfire manner. Diagnosis involves clinical examination supplemented by laboratory tests when needed. Treatment involves antiviral drugs like ganciclovir, foscarnet and cidofovir.
The document discusses various potential causes of optic disc swelling including:
1. Papilledema due to increased intracranial pressure from space occupying lesions, decreased CSF drainage, or idiopathic intracranial hypertension.
2. Optic neuritis which is inflammation of the optic nerve.
3. Anterior ischemic optic neuropathy (AION) which is infarction of the optic nerve head.
It provides details on presentations, ocular findings, and treatments for some of these conditions.
This document defines and describes papilledema, providing information on its pathophysiology, causes, symptoms, signs, grading, investigations, and treatment. Papilledema is passive swelling of the optic nerve head due to increased intracranial pressure. It is usually bilateral but can occasionally be unilateral. Increased ICP leads to increased optic nerve tissue pressure, altering the pressure gradient and causing swelling. Common causes include space occupying lesions, idiopathic intracranial hypertension, and cerebral edema. Signs include elevation and blurring of the optic disc margin. Treatment is directed at the underlying cause, with resolution of papilledema typically occurring within weeks of treatment.
This document discusses different types of ischemic optic neuropathy, including anterior ischemic optic neuropathy (AION), non-arteritic AION, arteritic AION, and posterior ischemic optic neuropathy. It describes the blood supply of the optic nerve head and risk factors, clinical features, investigations, treatments, and prognosis for each type. The main causes are reduced blood flow to the optic nerve head leading to infarction. AION is the most common cause of acute optic neuropathy in those over 50. Arteritic AION is caused by giant cell arteritis and requires high-dose steroid treatment to prevent blindness.
This document discusses optic disc swelling (papilledema) caused by increased intracranial pressure. It presents a case of a 35-year-old woman with severe headaches and vision issues. Examination found bilateral disc edema. CT scan revealed a brain tumor causing pressure. The patient was diagnosed with papilledema from the tumor and underwent surgery. The document then discusses the causes, presentation, stages, histopathology, and treatment of papilledema, emphasizing the importance of an eye exam for patients with headaches to identify potential intracranial issues.
This document provides an overview of neuro-ophthalmology topics including pupillary disorders, neuro-motility disorders, optic nerve disease, and visual field defects. It describes the anatomy and physiology related to these topics and discusses various conditions that can cause abnormalities, such as third nerve palsy, Horner's syndrome, optic neuritis, anterior ischemic optic neuropathy, papilledema, and visual field defects including arcuate scotomas. The document provides details on clinical features, causes, and treatments for these various neuro-ophthalmological conditions.
This document discusses papilledema, which is swelling of the optic disc due to increased intracranial pressure. It describes the pathophysiology as disturbance in axoplasmic flow and increased pressure along the optic nerve. Causes of bilateral papilledema include space occupying lesions, CSF flow blockage, increased CSF production, and idiopathic intracranial hypertension. Signs include optic disc elevation, blurred margins, filling of the physiological cup, and retinal or choroidal folds. The document also outlines the Frisen grading system for staging papilledema and differentiates papilledema from pseudopapilledema and optic atrophy.
The document discusses the anatomy and clinical assessment of the visual pathway, including the optic nerve, chiasm, and cranial nerves involved (oculomotor, trochlear, abducent). It describes testing such as visual fields and perimetry to localize lesions. Specific conditions are examined like optic neuritis, papilledema, Horner's syndrome, and third, fourth, and sixth nerve palsies. Clinical features and causes are outlined for localized evaluation of disorders affecting the anterior visual pathway.
1. The document discusses various eye conditions and symptoms, including how light is transmitted through the visual pathway and how vision is tested.
2. It describes papilledema, a sign of increased intracranial pressure that results in swelling of the optic disc. Causes include brain tumors and increased cerebral spinal fluid pressure.
3. Optic neuritis and optic atrophy are discussed as inflammatory and degenerative conditions of the optic nerve that can cause vision loss.
4. Hypertensive and diabetic retinopathies are summarized, noting how they are graded based on clinical appearance and prognosis. Diabetic retinopathy symptoms include blurred vision and can progress to vision loss if untreated.
This document provides an overview of optic neuropathies. It begins by defining optic neuropathies as disorders of the optic nerve and describes their clinical presentations. It then discusses various mechanisms and types of optic neuropathies including ischemic, compressive, infiltrative, and hereditary. Specific conditions like anterior ischemic optic neuropathy (AION), giant cell arteritis, optic neuritis, and Leber's hereditary optic neuropathy are described. Diagnostic testing and treatment approaches are also summarized for different optic neuropathies.
This document provides information on ischemic optic neuropathy (ION), including its causes and types. It discusses non-arteritic anterior ischemic optic neuropathy (NAION) and arteritic anterior ischemic optic neuropathy (AION), noting the differences in symptoms, risk factors, and treatment approaches. Central retinal artery occlusion (CRAO) is also covered, outlining the pathophysiology, signs, imaging studies and prognosis. Central retinal vein occlusion (CRVO) is summarized as well.
Papilledema is swelling of the optic disc caused by increased intracranial pressure. It is characterized by blurred disc margins and retinal nerve fiber layer edema. Increased CSF pressure is transmitted through the subarachnoid space and causes axoplasmic stasis in the optic nerve head. Papilledema is graded based on degree of disc elevation and obscuration from Frisen scale 0-5. Treatment involves addressing the underlying cause of increased ICP through medications, repeated lumbar punctures, or neurosurgery.
Systematic approach to pale disc
- Disc pallor is caused by loss of nerve fibers and decreased vascularity. A systematic approach is needed to determine the cause, including demographic data, history, exam, and tests.
- Key exam findings include visual acuity, fields, color vision, pupils, and detailed fundus exam of disc size, shape, color, rim, margins, and vasculature.
- Common causes are optic atrophy, ischemic optic neuropathy, glaucoma, toxic/nutritional neuropathies, and hereditary optic neuropathies. Careful exam can provide clues to the likely etiology.
This document discusses optic disc edema (papilledema), which is swelling of the optic disc due to increased intracranial pressure. It defines papilledema and differentiates it from pseudopapilledema. Symptoms, signs, investigations and treatment are described. Papilledema is caused by increased intracranial pressure disrupting axoplasmic flow in the optic nerve. Signs include blurred disc margins, retinal folds, and fullness of the optic cup. Treatment involves addressing the underlying cause to reduce pressure and prevent vision loss.
This document discusses painful ophthalmoplegia, which presents as periorbital or hemicranial pain, ipsilateral ocular motor palsies, and sensory loss in the trigeminal nerve distribution. Causes include aneurysms, carotid cavernous fistulas, cavernous sinus thrombosis, tumors, and infections. Evaluation involves imaging like MRI/CT/angiography. Management depends on the underlying cause but may include antibiotics, anticoagulation, surgery, or steroids. Prognosis depends on early diagnosis and treatment, with potential for residual neurological deficits.
Painful ophthalmoplegia refers to pain in the eye or forehead along with paralysis or weakness of the extraocular muscles. It can involve the third, fourth, and sixth cranial nerves as well as the oculosympathetic pathway. Common causes include lesions in the superior orbital fissure, cavernous sinus, or orbital apex. Diagnosis is made clinically and imaging such as MRI may help locate the lesion. Treatment depends on the underlying cause but may include antibiotics, steroids, or surgery.
This document provides information on neuro-ophthalmology topics including mydriasis, miosis, causes of pupil changes, cervical sympathetic ganglia, medications that cause pupil changes, neurological causes of pupil changes, and optic nerve and disc topics. It discusses Horner's syndrome, Adie's pupil, optic disc edema/papilledema, optic atrophy including primary, secondary, consecutive, and glaucomatous types. It provides details on clinical presentation, investigations, complications, and characteristics of different types of optic atrophy. Images are included showing examples like Foster Kennedy syndrome, optic disc edema, optic atrophy, and retinal vessel changes in glaucoma.
This document discusses different types of ischemic optic neuropathy including anterior ischemic optic neuropathy (AION), non-arteritic anterior ischemic optic neuropathy (NAION), arteritic anterior ischemic optic neuropathy (AAION), and posterior ischemic optic neuropathy (PION). NAION is the most common type, accounting for 90-95% of AION cases. AAION is caused by giant cell arteritis and results in more severe vision loss. Risk factors, clinical presentations, investigations, and treatments are described for each condition. A case report demonstrates the findings and management of a patient with AAION.
This document discusses various tests and examinations performed during an eye exam, including visual acuity testing, visual field testing, pupillary reactions testing, and ophthalmoscopy. It then provides details on specific eye conditions that may be identified during an exam, such as papilledema, optic neuritis, glaucoma, and cranial nerve palsies. Throughout, it emphasizes the importance of thoroughly testing visual acuity and visual fields and examining all cranial nerves if any abnormality is detected.
This document discusses neuro-ophthalmologic causes of headache. It begins by noting that headaches are a common complaint in ophthalmology and can be caused by issues with vision, photophobia, or cranial nerves. The document then examines primary headache syndromes like migraines and trigeminal autonomic cephalgias, as well as secondary causes such as dry eye, uveitis, giant cell arteritis, pituitary apoplexy, idiopathic intracranial hypertension, and more. It stresses the importance of a thorough history and exam to differentiate between primary and secondary headaches and identify potential vision-threatening conditions.
This document provides an overview of the anatomy and clinical assessment of the optic nerve in 3 paragraphs:
1) It describes the anatomy of the optic nerve, including its origin from the ganglion cells and path from the optic disc to the optic chiasm. It is composed of over 1 million axons and is divided into intraocular, intraorbital, intracanalicular, and intracranial portions.
2) Clinical assessment of the optic nerve involves testing visual acuity, color vision, visual fields, and the pupillary light reflex. Signs of optic nerve pathology include an afferent pupillary defect.
3) Different pathologies like papilledema, optic neuritis, and optic
Case presentation on Cavernous sinus thrombosisTareq Esteak
This document presents the case of a 55-year-old man admitted with a 4-day history of headache and drooping of the right eyelid. Examination revealed complete ptosis and ophthalmoplegia on the right side, along with sensory loss in the right V1 and V2 distributions. MRI showed a lesion involving the right cavernous sinus, sphenoidal sinus, and ethmoidal air sinus, with enhancement and restricted diffusion. The final diagnosis was right cavernous sinus thrombosis secondary to sphenoidal and ethmoidal sinusitis, with complete right internal carotid artery occlusion and an acute right-sided infarct. The patient was treated with antibiotics, anticoagulation, glycemic control
This document provides an overview of the cerebellum. It discusses the gross anatomy, radiographic appearance, development, functional divisions, blood supply, and common pathologies of the cerebellum. Key points covered include the connections between the cerebellum and brainstem, the cortical layers and circuitry, the phylogenetic and functional roles of different cerebellar regions, and common causes of cerebellar ataxia including vascular, infectious, autoimmune, metabolic, neoplastic and inherited etiologies. Diagrams are provided to illustrate cerebellar anatomy and examples of various cerebellar lesions.
Neuromyelitis optica (NMO), also known as Devic's disease, is an inflammatory disorder characterized by demyelination of the optic nerve and spinal cord. It is associated with antibodies against aquaporin-4 (AQP4-IgG). The disease predominantly affects women and typically presents with episodes of optic neuritis and transverse myelitis. MRI often shows long extensive lesions of the spinal cord. Treatment involves high-dose steroids for acute attacks and immunosuppressants like mycophenolate mofetil or rituximab to prevent relapses. Distinguishing NMO from multiple sclerosis is important for treatment, as some therapies effective for MS may worsen NMO.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
3. OUTLINE
Anatomy of Optic Nerve
Blood supply of Optic Nerve
Applied anatomy
Pathogenesis
Differentials
4. ANATOMY OF OPTIC NERVE
An outgrowth of brain
2nd cranial nerve
Comprised of axonal extension from ganglionic cell of retina
Optic disc to chiasma
Not covered with neurilemma : doesn’t regenerate when get cut
Sorrounded by meninges unlike other cranial nerves
5. PARTS OF OPTIC NERVE
Intraocular
Intraorbital
Intracanalicular
Intracerebral
7. ARTERIAL SUPPLY:
OPTIC NERVE
Internal carotid
artery
Ophthalmic artery
Central Retinal Artery
anterior part of the
retrobulbar nerve via
centrifugal arterioles
Short posterior ciliary
artery(6-12)
Supply the Optic nerve
head in Centripetal and
segmental fashion
Arteries & arterioles of
pial sheeth derived
from ophthalmic artery
PION
CRA
O
AION
9. VENOUS DRAINAGE
Optic nerve head : Central ratinal vein
Orbital part: Central retinal vein,Pial plexus
Intracranial part: Pial plexus<anterior cerebral vein
10. APPLIED ANTOMY
Papilledema occur as prelaminar axons swells from statis of
axoplasmic flow at the level of lamina cribrosa.
Insufficient blood flow through posterior ciliary artery due to
hypotension, thrombosis, vascular occlusion, vasculitis(GCA) causes
Optic nerve head infraction in leading to AION( optic disc swelled).
Insufficient blood flow through pial vasculature due to hypotension,
thrombosis, vascular occlution, vasculitis(GCA) causes Optic nerve
infraction post-laminar leading to PION ( optic disc normal).
11. APPLIED ANTOMY
Intracanalicular part of optic nerve is vulnarable to
injury in skull fracture.
Intracranial part of optic nerve is usually compressed
due to internal carotid artery aneurysm
CRVO : Papilledeama with widespread hemorrhage.
CRAO : Pale Retina with cherry red spot.
12. OPTIC DISC SWELLING
Optic disc swelling or disc edema may be defined as swelling of optic
nerve anterior to lamina cribrosa .
When found must be differentiated from Pseudopapilledema
Pseudopapilledema mostly congenital and physiological , doesn’t
need further workup
True Disc swelling is associated with numerous condition
14. Papilledema Pseudopapilledema
Definition Disc swelling due to raised
ICP
Appearance of disc swelling not due to
any disease state
Cause ICSOL,IIH, malignant
hypertension
Drusen, Myelinated nerve fiber,
Hypermetropia
Symptoms Transient vison loss,
enlarged blind spot
Usually asymptomatic, sometimes Arcuate
scotoma
Fundoscopy
Disc Small cupless/ill-defined cup Loss of cup occurs late
Color of Disc Hyperemic Yellowish
Obscuration of
disc blood vessel
present absent
Spontaneous
Venous pulsation
absent present
Exudates May be present absent
Fluorescein dye Dye leaks in disc No leakage
15. PAPILLEDEMA DRUSEN
Both disc are swollen with obscuration of
disc margins and vessel at disc
Retinal hemorrhage
Disc is elevated with visible yellowish
deposits within the optic nerve head
16. PAPILLEDEMA
DRUSEN
• Disc swelling, venous engorgement,
and vessel leakage shown by
fluorescein angiography, •Undilated capillary network with no
leakage of dye into the peripapillary region.
•Discrete foci of hyperfluorescence with
late staining of the drusen.
17. DRUSEN ( CT- ORBIT/HEAD)
• Calcification of the optic nerve insertion
bilaterally
• USG of eye demonstrates calcified (
drusen) optic nerve head
18. MYELINATED NERVE FIBER HYPERMETROPIA
• White, feathery ,Fanned out lesion
• Simulates disc edema
• Central retinal vessel crows in
small disc
• congested but no dialted vessels,
• Sponteneous venous pulsation
present
20. PAPILLEDEMA
Once true disc swelling is confirmed , it should be determined
whether it is related to an optic neuropathy or raised ICP.
Papilledema is usually reserve for optic swelling secondary to raised
ICP
All other disc swelling is called optic disc swelling or disc edema.
Other of the major causes of disc edema other than papilledema is
Papillitis or optic neuritis,AION
31. PAPILLITIS ( OPTIC NEURITIS)
Inflammation of optic papilla or optic disc is called papillitis or optic
neuritis
Usually associated with pain ,specially on eye movement
Dimness of vision
On examination: Imapired optic nerve function, Central scotoma
,RAPD present
Underlying disease :Demyelinating disease MS, NMO-SD,
If associated with retinal inflammation called neuroretinitis
Neuroretinitis usually never demyelinating. Causes include
Toxoplasmosis, Viral infection(CMV), Syphilis , Sarcoidosis.
32. MS NMO
T2WI- shows increased signal
intensity in small segmnt of
left optic nerve
T2WI-shows increased signal
intensity in large segment in
left optic nerve
34. PAPILLEDEMA VS PAPILLITIS
The main difference between papilledema and papillitis is
Visual equity and optic nerve function
oPapilledema: Intact
oPapillitis : Impaired
35. points Papilledema Papillitis
Definition Disc swelling due to Raised ICP Disc swelling due to Inflammation
Laterality Bilateral Usually Unilateral
Vision Transient obscuration of vision Sudden, persistent dimness of vision
Pain none During ocular movement
Etiology Raised ICP due to ICSOL,IIH,SSST
etc.
MS, NMO, Syphilis, Sarcoidosis etc.
Visual
acuity
intact reduced
Visual field Enlarge blind spot /tunnel vision Central or paracentral scotoma to complete
blindness
Fundoscop
y
Disc swelling with hemorrhage
;exudate
Disc swelling without hemorrhage ;exudate
Color
vision
Intact Impaired
Light Normal(RAPD absent) Relative afferent pupillary defect(RAPD
36. ANTERIOR ISCHEMIC OPTIC
NEUROPATHY (AION)
Ischemic optic neuropathy, at the optic nerve head
AION is traditionally divided into Arteritic (AAION) and Non-arteritic (NAION)
Arteritic AION (AAION) usually associated with GCA; comprises only 10% to
15% of all AION
Early differentiation of AAION and NAION is critical for medical management.
AAION is a true medical emergency because GCA can cause imminent
ischemic damage to the fellow optic nerve, retina, brain, and heart.
37. AION : PATHOPHYSIOLOGY
Optic disc swelling
Optic nerve head infraction
Occlusion of posterior
short ciliary artery
oVasculitis(GCA) ,Hypotension,
Thrombosis, Vascular occlusion
38. AION: ALTITUDINAL VISION LOSS
Superior segmental Disc pallor
corresponding to Inferior,
Altitudinal field of vision defect
on visual field test
39. Points Arteritic AION (AAION ) Non-arterictic AION (NAION)
sex Female> Male Male=Female
Age(y) >60 40-60
onset Acute Sub-acute, insidious
Visual Loss Profound Less profound
Second Eye
involvement
Within days to weeks Weeks to months
Associated symptoms Headache,Jaw claudication, scalp
tendeness
absent
Underlying disease Giant cell arteritis DM, HTN, Dyslipidemia
Disc Pallor> Hyperemia Hyperemia > pallor
ESR >90 <40
CRP raised normal
Response to steroid Responsive Non-responsive
Prognosis Untreated visual loss upto50-95%, 95%
cases fellow eye involvement
Spontaneous improvement up
to 43% cases;<30% cases
involvement of fellow eye
41. TREATMENT APPROACH TO
AION(DUE TO GCA)
Koster, M.J., Warrington, K.J. and Kermani, T.A., 2016. Update on the epidemiology and treatment of giant cell
arteritis. Current Treatment Options in Rheumatology, 2(2), pp.138-152.
42. AION VS OPTIC NEURITIS
Why do we need to differentiate?
Similarities in presentation:
I. Unilateral dimness of vision
II. Painful optic neuropathy
III. Optic nerve dysfunction: field, acuity,color vision,RAPD,Optic disc
swelling
IV. May Respond to steroids
43. Points Optic Neuritis AION
Age of onset 20-30 >60
Pain 92% cases, exacerbate on eye
movement
Periorbital but no change with eye
movement
Associated Sensory disturbance, Limb
weakness,
Ataxia, Bowel bladder dysfunction,
Headache,Jaw claudication, scalp
tendeness
onset Insidious ,progresses of hours to
days
Sudden onset, often notice upon
awekenig
Disc swelling Present only one third of the
cases, in rest its retrobulbar
Present in most of the cases
Field defect Central scotoma Altitudinal
MRI Enhancement of optic nerve No enhancement of optic nerve
Recovery Within 2-4 weeks Over months
prognosis Good prognosis poor
44. LEBER’S HERIDITARY OPTIC NEUROPATHY(LHON)
• Mitocondrial disease
• Bilateral involvement of optic nerve
• May occur at any age
• Acute phase present with optic disc
swelling and hyperemia
• Ultimately patient develops optic
atrophy
• Associated with cardiac conduction
defects, Tremor, limb
weakness(LHON plus)
46. HYPERTENSIVE RETINOPATHY
excessive cerebral
blood flow
breakdown of the
blood–brain
barrier
secondary
vasogenic edema
Papilledema
Precapillaries in the
posterior fundus
get occluded
ischemic process
leading to
fibrinoid necrosis
cytotoxic edema
48. DIABETIC PAPILLOPATHY
Benign Optic disc swelling , typically bilateral
Young juvenile diabetics
No or minimal effects on visual acuity and visual fields are typically restricted.
Usually occur in the absence of diabetic retinopathy
36% of cases of diabetic papillopathy progressing to NAION.
Usually a diagnosis of exclution
Spontaneous resolution within 2-10 months without any optic atrophy
The exact pathogenesis is unclear, but is believed to occur due to disruption of the
peripapillary vasculature
Wallace, I.R., Mulholland, D.A. and Lindsay, J.R., 2012. Diabetic papillopathy: an uncommon cause of bilateral optic disc swelling. QJM: An
49. DIABETIC
PAPILLOPATHY
(A and B) Bilateral marked swelling
and superficial flame haemorrhages in
the left eye.
Note, absence of significant diabetic
retinopathy.
(C and D) Swelling gradually resolving
without atrophy 3 months later.
Treatment:
• Good glycemic control
• regular intervals with close
monitoring.
51. CRVO
Pathogenesis
Papilledema and Hemorrhage
Hypoxia
Stagnation
Venous occlution
Due to HTN, DM, Dyslipidemia,
Hyperviscosity
Examination finding
Visual acuity : impaired
RAPD : present
Treatment:
I. Intra-vitreal injection :1st line: VEGF
inhibitor, reduce macular edema
II. Intra-vitreal injection: 2nd
line,triamsinolone,dexamethasone
III. Neovascularization: PRP
52. IIH
Idiopathic intracranial hypertension is characterised by signs and
symptoms of raised intracranial pressure (ICP) with no established
pathogenesis.
predominantly affects young, obese women
Pathogenesis has not been fully elucidated
Three main proposed mechanism
1. increased venous sinus pressure,
2. decreased CSF drainage across the arachnoid granulations or
lymphatics
3. enhanced CSF production at the choroid plexus
54. NEUROIMAGING
:IIH
(A)T1 - MRI; sagittal; empty Sella
turcica (arrow) presents in 70% of
patients with idiopathic intracranial
hypertension.
(B) T2 weighted MRI; axial; distension
of the optic nerve sheath (arrows)
has been reported in 45% of patients
with the disorder.28
(C) MRI venography; posterior view;
hypoplastic right transverse sinus
(arrow).
(D) T2 weighted MRI; axial; flattening of
posterior globes (arrows) can be seen in
80% of patients.
55. FUNDAL PHOTOGRAPHS WITH
CORRESPONDING SPECTRAL
DOMAIN OPTICAL
COHERENCE
TOMOGRAPHY(OCT)
Fundal photographs and optical
coherence tomography can be
used for the diagnosis of
papilledema.
(A) Fundal photograph and (B)
corresponding optical coherence
tomography (healthy control).
(C) Fundal photograph of
papilloedema with an elevated
disc and peripapillary halo,
(D) corresponding OCT showing
an increase in retinal nerve fibre
layer thickness in IIH
62. Figure : Sagittal sinus thrombosis.
(A) MR venogram showing absent venous
flow signal in the middle third of the
superior sagittal sinus (white arrows)
(B) Axial gadolinium-enhanced T1-weighted
MR scan showing an irregular filling defect of
the superior sagittal sinus (white arrow)
(C) Sagittal gadolinium-enhanced T1-
weighted MR scan also showing a focal filling
defect indicating thrombus (white arrow)
(D) Axial susceptibility-weighted imaging
showing low signal indicating blood products
(thrombus) in the superior sagittal sinus
(white arrow)
63. TREATMENT
Should be started as soon as the diagnosis of CVT is clearly confirmed
- Rapid anticoagulant therapy
- Treatment of underlying cause (eg, dehydration, sepsis, stopping
any prothrombotic medications)
- Control of seizures
- Management of intracranial hypertension if required.
64. COMPRESIVE OPTIC NEUROPATHY
• Lesion may compress or infiltrate the intraorbital, intracranial or prechiasmal optic nerve
• Large and intraorbital lesions often produce optic disc swelling
Presentation
o Progressive unilateral optic neuropathy
o Usually no pain with eye movement
o Headache occurs if raised ICP or involvement of Trigeminal nerve
o Proptosis is common in orbital lesion
o Cranial nerve palsys occur if lesion extending to orbital apex, superior orbital fissure or
cavernous sinus.
o Early disc change: Swelling ; Late change : Optic Atrophy
66. OPTIC SHEATH MENINGIOMA GRAVES
OPTHALMOPATHY
,T1-w MRI reveals an contrast enhancing
mass surrounding the optic nerve.(Red Arrow)
T1WI:Bilateral Fusiform enlargement of
medial rectus ;Right compressing the
optic nerve
67. TOXIN INDUCED NEUROPATHY/ TOXIC
AMBLYOPIA
• Patient presents with sudden vison loss
• Abrupt onset central/cecocentral scotoma
• Associated nausea, vomiting, abdominal pain
• Metabolic acidosis is one of the hallmark
• Initially optic disc is swollen but eventually
patient develops optic atrophy
• Treatment:
I. Lavage
II. IV NaHCO3
III. Antidote: Ethanol, fomepizole
IV. Others: Folinic acid
V. Hemodialysis
III
IV
69. TAKE HOME MESSAGE
I. Papilledema must be differentiated from Pseudopapilledema cause true
papilledema needs extensive workup and specific treatment but
pseudopapilledema doesn’t.
II. Not all bilateral optic disc swellings are papilledema e.g,NMO,anti-
MOG,Toxic amblyopia, Diabetic papillopathy etc.
III. Optic neuritis and AION both may present with painful visual loss but
should be differentiated early specific management and better prognosis.
IV. Early differentiation of AAION and NAION is critical for medical management
V. Though IIH is called idiopathic there are multiple proposed mechanism for
its pathogenesis
VI. Diabetic and hypertensive patient both can present with Bilateral optic disc
swelling. In hypertension it’s a medical emergency but in diabetic papillopathy it
self limiting.